159 related articles for article (PubMed ID: 20528641)
41. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.
Kanbay M; Yildirir A; Bozbas H; Ulus T; Bilgi M; Muderrisoglu H; Akcay A; Ozdemir FN
Ren Fail; 2005; 27(3):297-303. PubMed ID: 15957546
[TBL] [Abstract][Full Text] [Related]
42. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
Ibrahim MM; el-Boghdadly B; Zaghloul SS
J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
[TBL] [Abstract][Full Text] [Related]
43. Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus.
Ferdinand KC; Flack JM; Saunders E; Victor R; Watson K; Kursun A; Jamieson MJ; Shi H
J Clin Hypertens (Greenwich); 2009 Oct; 11(10):585-93. PubMed ID: 19817942
[TBL] [Abstract][Full Text] [Related]
44. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
45. Effect of food on the bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
Chung M; Calcagni A; Glue P; Bramson C
J Clin Pharmacol; 2006 Oct; 46(10):1212-6. PubMed ID: 16988211
[No Abstract] [Full Text] [Related]
46. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
47. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
48. Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.
Fogari R; Preti P; Zoppi A; Lazzari P; Corradi L; Fogari E; Ciccarelli L; Derosa G
Eur J Clin Pharmacol; 2006 Oct; 62(10):817-22. PubMed ID: 16896785
[TBL] [Abstract][Full Text] [Related]
49. Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia.
Lin CP; Hsu TJ; Tung YC; Hsiao FC; Chou SH; Lin YS; Chen SW; Chu PH
J Am Heart Assoc; 2024 May; 13(9):e033780. PubMed ID: 38686894
[TBL] [Abstract][Full Text] [Related]
50. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
[TBL] [Abstract][Full Text] [Related]
52. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
McKeage K; Siddiqui MA
Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
[TBL] [Abstract][Full Text] [Related]
53. Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.
Jukema JW; van der Hoorn JW
Expert Opin Pharmacother; 2004 Feb; 5(2):459-68. PubMed ID: 14996641
[TBL] [Abstract][Full Text] [Related]
54. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
55. Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia.
Cohn JN; Wilson DJ; Neutel J; Houston M; Weinberger MH; Grimm R; Smith DH; Sun W
Am J Hypertens; 2009 Feb; 22(2):137-44. PubMed ID: 19057518
[TBL] [Abstract][Full Text] [Related]
56. Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.
Dorval JF; Anderson T; Buithieu J; Chan S; Hutchison S; Huynh T; Jobin J; Lonn E; Poirier P; Title L; Walling A; Tran T; Boudreau G; Charbonneau F; Genest J
Am J Cardiol; 2005 Jan; 95(2):249-53. PubMed ID: 15642561
[TBL] [Abstract][Full Text] [Related]
57. Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?
Zeng R; Wang M; Zhang L
Med Sci Monit; 2016 Jul; 22():2648-55. PubMed ID: 27459306
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
[TBL] [Abstract][Full Text] [Related]
59. Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit.
Cardiovasc J S Afr; 2007; 18(1):43-4. PubMed ID: 17392998
[No Abstract] [Full Text] [Related]
60. [Safety and antihypertensive efficacy of the dihydropyridine calcium antagonist Amlodipine besylate--results from an observational study in 9,672 patients].
Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):115-21. PubMed ID: 15662901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
